| For: | Abdalla MMI. Role of visfatin in obesity-induced insulin resistance. World J Clin Cases 2022; 10(30): 10840-10851 [PMID: 36338223 DOI: 10.12998/wjcc.v10.i30.10840] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i30/10840.htm |
| Number | Citing Articles |
| 1 |
Ana Paula dos Santos Xavier Braga, Diana Matos Silva, Deborah de Farias Lelis, Rogério Estevam Farias, Alanna Fernandes Paraíso, Sérgio Henrique Sousa Santos, Andrea Maria Eleutério de Barros Lima Martins, João Marcus Oliveira Andrade. Apelin and Visfatin Expression in Placental Tissue in Women With Preeclampsia and Overweight/Obesity. Biological Research For Nursing 2023; 25(4) doi: 10.1177/10998004231178835
|
| 2 |
Francesco Saverio Ragusa, Toshiko Tanaka, Nicola Veronese, Pasquale Mansueto, Ligia J. Dominguez, Mario Barbagallo, Luigi Ferrucci. Weight of time: exploring the link between obesity and aging. Aging Clinical and Experimental Research 2025; 37(1) doi: 10.1007/s40520-025-03106-4
|
| 3 |
Lizhen Zhou, Jishen Li, Ziyang Dong, Xiaxia Du, Yuqi Sun, Shan Tong. Aging epicardial adipose tissue: a metabolic-endocrine network driving vascular calcification. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1817572
|
| 4 |
Ivana Vucenik, Laundette P. Jones, John C. McLenithan. Metabolic Syndrome. 2023; doi: 10.1007/978-3-319-12125-3_50-2
|
| 5 |
Andrei Prodaniuc, Cornelia Amalinei, Irina Draga Caruntu, Adriana Laura Riscanu, Adriana Grigoraș. Parallel Pathways, Divergent Outcomes: Adipose Tissue–Neural Crosstalk in Depression and Obesity. Journal of Clinical Medicine 2025; 14(23) doi: 10.3390/jcm14238307
|
| 6 |
Shuaihang Chen, Kaihan Wu, Yani Ke, Shanshan Chen, Ran He, Qin Zhang, Chenlu Shen, Qicong Li, Yuting Ruan, Yuqing Zhu, Keying Du, Jie Hu, Shan Liu. Association of circulating visfatin level and metabolic fatty liver disease: An updated meta-analysis and systematic review. Medicine 2024; 103(37) doi: 10.1097/MD.0000000000039613
|
| 7 |
Alicja Ewa Ratajczak-Pawłowska, Aleksandra Szymczak-Tomczak, Szymon Hryhorowicz, Agnieszka Zawada, Kinga Skoracka, Anna Maria Rychter, Marzena Skrzypczak-Zielińska, Ryszard Słomski, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak. Relationship of visfatin with obesity and osteoporosis in patients with inflammatory bowel disease: a narrative review. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1533955
|
| 8 |
Bo Sun Joo, Ju-Hwa Baek, Min Jung Park, Hyunseok Choi, Ji Myung Choi, Jae Woo Lee. Effects of peptides derived from active sites of visfatin on wound healing. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-06751-x
|
| 9 |
Marie Binvignat, Jérémie Sellam, Francis Berenbaum, David T. Felson. The role of obesity and adipose tissue dysfunction in osteoarthritis pain. Nature Reviews Rheumatology 2024; 20(9) doi: 10.1038/s41584-024-01143-3
|
| 10 |
Kristina Petruliene, Alanta Zilinskiene, Ruta Vaiciuniene, Kestutis Vaiciunas, Inga Arune Bumblyte, Egle Dalinkeviciene. Obesity and Its Clinical Implications in End-Stage Kidney Disease. Medicina 2026; 62(1) doi: 10.3390/medicina62010211
|
| 11 |
Dimiter Avtanski, Radoslav Stojchevski. Adipose Tissue. Contemporary Endocrinology 2024; doi: 10.1007/978-3-031-72570-8_1
|
| 12 |
T.A. Sonia, Chandra P. Sharma. Oral Delivery of Insulin. 2026; doi: 10.1016/B978-0-443-30272-5.00007-X
|
| 13 |
Samuel A. McFadden, Yimin Fang, Kathleen Quinn, Mackenzie R. Peck, Jenelle E. Chapman, Tiarra Hill, Andrzej Bartke, Erin R. Hascup, Kevin N. Hascup. Surgical removal of visceral adipose tissue has therapeutic benefit in male APPNL-F mice. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1681801
|
| 14 |
Yubing Lu, Yishan Xin, Hongyan Li, Xinyu Fang, Yunzhi Lin, Chaofan Zhang. Dual roles and mechanisms of adipokines in nerve injury repair and pain regulation: a research review. International Immunopharmacology 2026; 183 doi: 10.1016/j.intimp.2026.116880
|
| 15 |
Jarosław Nuszkiewicz, Jolanta Czuczejko, Wiktor Dróżdż, Alina Woźniak, Bogdan Małkowski, Karolina Szewczyk-Golec. Concentration of Selected Adipokines and Factors Regulating Carbohydrate Metabolism in Patients with Head and Neck Cancer in Respect to Their Body Mass Index. International Journal of Molecular Sciences 2023; 24(4) doi: 10.3390/ijms24043283
|
| 16 |
Marta Pelczyńska, Ewa Miller-Kasprzak, Marcin Piątkowski, Roksana Mazurek, Mateusz Klause, Anna Suchecka, Magdalena Bucoń, Paweł Bogdański. The Role of Adipokines and Myokines in the Pathogenesis of Different Obesity Phenotypes—New Perspectives. Antioxidants 2023; 12(12) doi: 10.3390/antiox12122046
|
| 17 |
Physiological regulation of moderate-intensity exercise in improving the biomarkers visfatin and myonectin as a modulator of increasing metabolic performance in obese. Journal of Basic and Clinical Physiology and Pharmacology 2025; 36(2-3) doi: 10.1515/jbcpp-2024-0207
|
| 18 |
Klaudia Stocerz, Arkadiusz Sokal, Mariusz Kuczera, Monika Kadela-Tomanek, Kinga Orlińska, Paweł Olczyk. Selected adipokines as potential prognostic and diagnostic agents in treatment of metabolic disorders associated with obesity. Annales Academiae Medicae Silesiensis 2024; 78 doi: 10.18794/aams/186748
|
| 19 |
O.T. Romaniuk , H.E. Sklyarova , О.О. Tiutiunnyk , I.S. Fomenko , E.Y. Sklyarov , L.I. Kobylinska, G. VariShandor . THE ROLE OF ADIPONECTIN, VISFATIN AND IRISIN IN THE PATHOGENESIS AND TREATMENT OF ARTERIAL HYPERTENSION . Medical Science of Ukraine (MSU) 2024; 20(3) doi: 10.32345/2664-4738.3.2024.04
|
| 20 |
Chang‐Yu Song, Chih‐Ying Wu, Chih‐Yang Lin, Chun‐Hao Tsai, Hsien‐Te Chen, Yi‐Chin Fong, Li‐Chai Chen, Chih‐Hsin Tang. The stimulation of exosome generation by visfatin polarizes M2 macrophages and enhances the motility of chondrosarcoma. Environmental Toxicology 2024; 39(7) doi: 10.1002/tox.24236
|
| 21 |
Fernanda Isadora Corona-Meraz, Mónica Vázquez-Del Mercado, Flavio Sandoval-García, Jesus-Aureliano Robles-De Anda, Alvaro-Jovanny Tovar-Cuevas, Roberto-Carlos Rosales-Gómez, Milton-Omar Guzmán-Ornelas, Daniel González-Inostroz, Miguel Peña-Nava, Beatriz-Teresita Martín-Márquez. Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome. Journal of Clinical Medicine 2024; 13(7) doi: 10.3390/jcm13071988
|
| 22 |
Chang-Yu Song, Shang-Lin Hsieh, Shang-Yu Yang, Chih-Yang Lin, Shih-Wei Wang, Chun-Hao Tsai, Yuan-Shun Lo, Yi-Chin Fong, Chih-Hsin Tang. Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma. International Journal of Molecular Sciences 2024; 25(10) doi: 10.3390/ijms25105142
|
| 23 |
Andrea Mulas, Sofia Cienfuegos, Mark Ezpeleta, Shuhao Lin, Vasiliki Pavlou, Krista A. Varady. Effect of intermittent fasting on circulating inflammatory markers in obesity: A review of human trials. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1146924
|
| 24 |
Lara J. Bou Malhab, Vidhya A. Nair, Rizwan Qaisar, Gianfranco Pintus, Wael M. Abdel-Rahman. Towards Understanding the Development of Breast Cancer: The Role of RhoJ in the Obesity Microenvironment. Cells 2024; 13(2) doi: 10.3390/cells13020174
|
| 25 |
Duygu Tozcu Yilmaz, Mehmet Ali Gul, Mustafa Capraz, Hatice Dortok Demir, Akin Tekcan. Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers. Biomedicines 2025; 13(11) doi: 10.3390/biomedicines13112619
|
| 26 |
Esther Ugo Alum, Ernest Nnamdi Ikpozu, Christian Emeka Offor, Ikechuku Okorie Igwenyi, Israel Olusegun Obaroh, Udu Ama Ibiam, Chris U. A. Ukaidi. RNA-based diagnostic innovations: A new frontier in diabetes diagnosis and management. Diabetes & Vascular Disease Research 2025; 22(2) doi: 10.1177/14791641251334726
|
| 27 |
Thyparambil Aravindakshan Pramodkumar, Wesley Hannah, Ranjit Mohan Anjana, Uma Ram, Mangesh Tiwaskar, Kuppan Gokulakrishnan, Polina V Popova, Viswanathan Mohan. Biomarkers of Gestational Diabetes Mellitus: Mechanisms, Advances, and Clinical Utility. Journal of The Association of Physicians of India 2025; 73(2) doi: 10.59556/japi.73.0849
|
| 28 |
Evgenii Gusev, Alexey Sarapultsev, Yulia Zhuravleva. Insulin Resistance and Inflammation. International Journal of Molecular Sciences 2026; 27(3) doi: 10.3390/ijms27031237
|
| 29 |
Ilinca Savulescu-Fiedler, Razvan Mihalcea, Serban Dragosloveanu, Cristian Scheau, Radu Octavian Baz, Ana Caruntu, Andreea-Elena Scheau, Constantin Caruntu, Serban Nicolae Benea. The Interplay between Obesity and Inflammation. Life 2024; 14(7) doi: 10.3390/life14070856
|
| 30 |
Abeer Ameen Mustafa, Rafal Mustafa Tuama, Marwa Abdulsalam Kader. Association of novel and classical serum adipokines with insulin resistance, visceral adiposity, and metabolic risk in middle-aged adults: a cross-sectional study. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2026; 22(1) doi: 10.22141/2224-0721.22.1.2026.1679
|
| 31 |
Jaime Moreno, Lise Lotte Gluud, Elisabeth D. Galsgaard, Henning Hvid, Gianluca Mazzoni, Vivek Das, Xianmin Zhu. Identification of ligand and receptor interactions in CKD and MASH through the integration of single cell and spatial transcriptomics. PLOS ONE 2024; 19(5) doi: 10.1371/journal.pone.0302853
|
| 32 |
I. N. Salman, N. U. G. Mohammed, S. E. Atta, B. A. Abed, R. Salim. Serum visfatin in patients with type two diabetic retinopathy. Diabetes mellitus 2024; 27(5) doi: 10.14341/DM13165
|
| 33 |
Rui-Ming Wen, Hai-Xia Wang. Effect of adipokines on bone marrow mesenchymal stem cell function. World Journal of Stem Cells 2025; 17(5): 106150 doi: 10.4252/wjsc.v17.i5.106150
|
| 34 |
Cindy Bandala, Jazmín Carro-Rodríguez, Noemí Cárdenas-Rodríguez, Itzel Peña-Montero, Modesto Gómez-López, Ana Paola Hernández-Roldán, Juan Carlos Huerta-Cruz, Felipe Muñoz-González, Iván Ignacio-Mejía, Brayan Domínguez, Eleazar Lara-Padilla. Comparative Effects of Gymnema sylvestre and Berberine on Adipokines, Body Composition, and Metabolic Parameters in Obese Patients: A Randomized Study. Nutrients 2024; 16(14) doi: 10.3390/nu16142284
|
| 35 |
Yu Zhang, Guize Feng, Weidong Zhang, Xia Liu. Natural Compounds Exert Anti‐Obesity Effects by Regulating Cytokines. Phytotherapy Research 2025; 39(6) doi: 10.1002/ptr.8508
|
| 36 |
Noor Mohammed Al-Dhafiri. Association Between Visfatin Levels and Male Infertility in Obese Patients: A Biomarker-Based Study. European Journal of Ecology, Biology and Agriculture 2026; 3(3) doi: 10.59324/ejeba.2026.3(3).02
|
| 37 |
Dharani M, Shenbagadevi S, Jothilakshmi M V. Serum Visfatin Levels in Women with Newly Diagnosed Polycystic Ovarian Disease: A Cross-Sectional Study. International Journal of Health Sciences and Research 2026; doi: 10.52403/ijhsr.20260327
|
| 38 |
Yue Zhang, Yarui Zhao, Yijie Luo, Lei Wang, Jing Liao, Huixia Lu, Xinyu Zhang, Xiaoping Ji. Adipose-Derived Proinflammatory Visfatin Promotes Vascular Calcification via TLR4 and is Suppressed by Empagliflozin. Inflammation 2026; 49(1) doi: 10.1007/s10753-026-02507-5
|
| 39 |
Constantine E. Kosmas, Maria D. Bousvarou, Christina E. Kostara, Evangelia J. Papakonstantinou, Evdokia Salamou, Eliscer Guzman. Insulin resistance and cardiovascular disease. Journal of International Medical Research 2023; 51(3) doi: 10.1177/03000605231164548
|
| 40 |
Sebastian Stępień, Paweł Olczyk, Joanna Gola, Katarzyna Komosińska-Vassev, Aleksandra Mielczarek-Palacz. The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer. Cells 2023; 12(8) doi: 10.3390/cells12081118
|
| 41 |
Marina Aparecida dos Santos, Raul Hernandes Bortolin, Alvaro Cerda, Raquel de Oliveira, Tamires Invencioni Moraes Stefani, Cristina Moreno Fajardo, Egídio Lima Dorea, Márcia Martins Silveira Bernik, Nágila Raquel Teixeira Damasceno, Mario Hiroyuki Hirata, Rosario Dominguez Crespo Hirata. Variants in GHRL, RETN, and PLIN1 are associated with obesity, diabetes, and metabolic syndrome, and influence food consumption in adults with obesity. Nutrition Research 2025; 134 doi: 10.1016/j.nutres.2024.12.005
|
| 42 |
Yan-Hui Zhang, Dong Liang. Magnetic resonance imaging combined with serum endolipin and galactagoglobin-3 to diagnose cerebral infarction in the elderly with diabetes mellitus. World Journal of Diabetes 2024; 15(7): 1509-1517 doi: 10.4239/wjd.v15.i7.1509
|
| 43 |
S. S. Tkachenko, O. G. Rodynskyi, Y. Yu. Reshetnikova. MECHANISMS OF INTERRELATIONSHIP BETWEEN OBESITY AND DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME. Bulletin of Problems Biology and Medicine 2025; 1(1) doi: 10.29254/2077-4214-2025-2-177-121-129
|
| 44 |
Soudabeh Hamedi-Shahraki, Filiz Mercantepe, Farshad Amirkhizi, Aleksandra Klisic. Clustering adipokines, metabolic, oxidative stress, and inflammatory markers associated with cardiovascular disease risk in patients with metabolic syndrome. Diabetology & Metabolic Syndrome 2026; 18(1) doi: 10.1186/s13098-026-02140-0
|
| 45 |
Umesh Zadgaonkar. The Interplay Between Adipokines and Body Composition in Obesity and Metabolic Diseases. Cureus 2025; doi: 10.7759/cureus.78050
|
| 46 |
Alexandra Slon, Michal Mazaki-Tovi. Alterations in serum concentrations of visfatin and betatrophin in dogs with diabetes mellitus. Domestic Animal Endocrinology 2025; 91 doi: 10.1016/j.domaniend.2025.106914
|
| 47 |
Zichen Shao, Qinqin Deng, Ling Cheng, Fo Yang. Integrated multi-omics and single-cell transcriptomic analysis reveals shared molecular mechanisms and cell–cell communication signatures in gout and metabolic syndrome. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1749788
|
| 48 |
Atilla Engin. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology 2024; 1460 doi: 10.1007/978-3-031-63657-8_17
|
| 49 |
Wilson José S. Pedro, Flávio V. Barbosa Júnior, Fernanda N. B. R. Alves, Lenita V. Braga, Larissa R. Alves, João Pedro R. Afonso, Iranse O. Silva, Carlos Hassel M. Silva, Sergio Vencio, Paolo Capodaglio, Luis V. F. Oliveira, Wilson R. Freitas Júnior. Role of Adipokines Chemerin, Visfatin, and Omentin in Obesity and Their Inflammatory and Metabolic Implications. Biomedicines 2025; 13(10) doi: 10.3390/biomedicines13102321
|
| 50 |
Ewa Śliwicka, Natalia Popierz-Rydlewska, Anna Straburzyńska-Lupa, Jivko Nikolov, Łucja Pilaczyńska-Szcześniak, Anna Gogojewicz. Prevention Is Better than Cure—Body Composition and Glycolipid Metabolism after a 24-Week Physical Activity Program without Nutritional Intervention in Healthy Sedentary Women. Nutrients 2024; 16(15) doi: 10.3390/nu16152536
|
| 51 |
Agnieszka Wesołek-Leszczyńska, Katarzyna Pastusiak, Paweł Bogdański, Monika Szulińska. Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?. Diabetes, Metabolic Syndrome and Obesity 2024; doi: 10.2147/DMSO.S460226
|
| 52 |
Praveen Kumar Chandra Sekar, Ramakrishnan Veerabathiran. Genes linked to obesity-related infertility: bridging the knowledge gap. Reproductive and Developmental Medicine 2024; 8(2) doi: 10.1097/RD9.0000000000000096
|
| 53 |
N. A. Shnayder, V. V. Grechkina, M. Ya. Kissin, D. V. Dmitrenko, R. F. Nasyrova. Role of neuropeptide Y in development of valproate-induced eating behaviour disorder. Epilepsy and paroxysmal conditions 2025; 16(4) doi: 10.17749/2077-8333/epi.par.con.2024.207
|
| 54 |
Ruchi Keswani, Vaishnavi G. Thorat, Chandragouda R. Patil, Shvetank Bhatt. Exploring the role of adipocytokines in obesity associated depression. Drug Discovery Today 2025; 30(12) doi: 10.1016/j.drudis.2025.104509
|
| 55 |
Cristina Maria Marginean, Denisa Pirscoveanu, Sergiu Marian Cazacu, Marian Sorin Popescu, Iulia Cristina Marginean, George Alexandru Iacob, Mihaela Popescu. Non-Alcoholic Fatty Liver Disease, Awareness of a Diagnostic Challenge—A Clinician’s Perspective. Gastroenterology Insights 2024; 15(4) doi: 10.3390/gastroent15040071
|
| 56 |
Ivana Vucenik, Laundette P. Jones, John C. McLenithan. Metabolic Syndrome. 2023; doi: 10.1007/978-3-031-40116-9_50
|
| 57 |
Aleksandra Stangret, Anna Wnuk, Zbigniew Lewandowski, Marta Chołuj, Marta Skoda, Dariusz Szukiewicz, Włodzimierz Sawicki, Krzysztof Cendrowski. Adipokine visfatin as a response of an efficient placenta to key pregnancy risk factors. Placenta 2025; 172 doi: 10.1016/j.placenta.2025.11.007
|
| 58 |
Marco Calcagno, Pietro Serra, Andrea Etrusco, Chrysoula Margioula-Siarkou, Sanja Terzic, Andrea Giannini, Simone Garzon, Federico Ferrari, Miriam Dellino, Antonio Simone Laganà. A bitter pill to swallow: adjustments to oral contraceptive pill use in polycystic ovary syndrome. Expert Opinion on Pharmacotherapy 2024; 25(9) doi: 10.1080/14656566.2024.2371977
|
| 59 |
Mostafa Saleh Ahmed, Eman AE Badr, Mohamed FA Assar. Visfatin (rs3801266) and Adiponutrin (rs738409) gene single nucleotide polymorphisms in patients with Hashimoto’s thyroiditis. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10437-y
|
| 60 |
Ömer Faruk Kuzu, Emre Hoca, Evrim Çakır, Hayriye Esra Ataoğlu. The Effect of Visfatin Levels on Blood Pressure and Cardiac Risk Factors in Patients with Acromegaly. Istanbul Medical Journal 2025; 26(4) doi: 10.4274/imj.galenos.2025.60307
|
| 61 |
Fa-Shun Liu, Song Wang, Xian-Shan Guo, Zhen-Xiong Ye, Hong-Ya Zhang, Zhen Li. State of art on the mechanisms of laparoscopic sleeve gastrectomy in treating type 2 diabetes mellitus. World Journal of Diabetes 2023; 14(6): 632-655 doi: 10.4239/wjd.v14.i6.632
Abstract(965) |
Core Tip(796) |
Full Article(HTML)(3418)
|
Full Article (PDF)-2431K(308)
|
Full Article with Cover (PDF)-2636K(242)
|
Full Article (Word)-785K(62)
|
Full Article (XML)-486K(160)
|
Audio-371K(12)
|
Peer-Review Report-190K(164)
|
Answering Reviewers-66K(162)
|
Times Cited (6)
|
Total Visits (4958)
|
Open
|
| 62 |
Enas El Saftawy, Mansour Alghamdi, Basma Emad Aboulhoda. Interplay of obesity and parasitic infection: current evidence of immunogenesis, tumorigenesis and leptin receptor involvement. Nutrition & Metabolism 2025; 22(1) doi: 10.1186/s12986-025-00972-7
|
| 63 |
Marleen Würfel, Matthias Blüher, Michael Stumvoll, Thomas Ebert, Peter Kovacs, Anke Tönjes, Jana Breitfeld. Adipokines as Clinically Relevant Therapeutic Targets in Obesity. Biomedicines 2023; 11(5) doi: 10.3390/biomedicines11051427
|
| 64 |
Dariusz Szukiewicz. Potential Therapeutic Exploitation of G Protein-Coupled Receptor 120 (GPR120/FFAR4) Signaling in Obesity-Related Metabolic Disorders. International Journal of Molecular Sciences 2025; 26(6) doi: 10.3390/ijms26062501
|
| 65 |
N. V. Zaichko, O. P. Bobetska . Insight on Visfatin as cardiovascular dysfunction metabolic factor (literature review). Reports of Vinnytsia National Medical University 2024; 28(1) doi: 10.31393/reports-vnmedical-2024-28(1)-26
|
| 66 |
Andrea L. Cote, Chad J. Munger, Alison E. Ringel. Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions. Cell Reports 2025; 44(2) doi: 10.1016/j.celrep.2025.115234
|
| 67 |
Gbolahan Olatunji, Emmanuel Kokori, Ravi Patel, Dhwani Jignesh Shah, Yusuf Ismaila Ajayi, Osadebamwen Osaghae, Chikodili Nebuwa, Chijindu Nwakama, Cynthia Chisom Edeh, Nicholas Aderinto. The role of visfatin as a biomarker in cardiovascular disease: a systematic review of its predictive and diagnostic potential. International Journal of Surgery: Global Health 2026; 9(2) doi: 10.1097/GH9.0000000000000611
|
| 68 |
Birendra Kumar Jha, Mingma Lhamu Sherpa, Mohammad Imran, Yousuf Mohammed, Laxmi Akhileshwar Jha, Keshav Raj Paudel, Saurav Kumar Jha. Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology. Diabetology 2023; 4(2) doi: 10.3390/diabetology4020015
|
| 69 |
Dimitrios Tsilingiris, Natalia G. Vallianou, Nikolaos Spyrou, Dimitris Kounatidis, Gerasimos Socrates Christodoulatos, Irene Karampela, Maria Dalamaga. Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges. Current Obesity Reports 2023; 13(1) doi: 10.1007/s13679-023-00542-z
|
| 70 |
Caijie Shen, Renyuan Fang, Jian Wang, Nan Wu, Shuangsuang Wang, Tian Shu, Jiating Dai, Mingjun Feng, Xiaomin Chen. Visfatin aggravates transverse aortic constriction‐induced cardiac remodelling by enhancing macrophage‐mediated oxidative stress in mice. Journal of Cellular and Molecular Medicine 2023; 27(17) doi: 10.1111/jcmm.17854
|
| 71 |
Mattia Garutti, Marianna Sirico, Claudia Noto, Lorenzo Foffano, Mark Hopkins, Fabio Puglisi. Hallmarks of Appetite: A Comprehensive Review of Hunger, Appetite, Satiation, and Satiety. Current Obesity Reports 2025; 14(1) doi: 10.1007/s13679-024-00604-w
|